GCM
IRWD icon

Graham Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Graham Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,821
Closed -$108K – 1372
2026
Q1 		$108K Buy
+30,821
New +$126K ﹤0.01% 1033
2025
Q3 		– Sell
-523,378
Closed -$375K – 1450
2025
Q2 		$375K Buy
523,378
+319,840
+157% +$251K 0.01% 921
2025
Q1 		$299K Buy
203,538
+140,506
+223% +$335K 0.01% 998
2024
Q4 		$279K Sell
63,032
-44,938
-42% -$182K ﹤0.01% 961
2024
Q3 		$445K Buy
+107,970
New +$580K 0.01% 667
2024
Q2 		– Sell
-13,537
Closed -$118K – 1189
2024
Q1 		$118K Buy
+13,537
New +$164K ﹤0.01% 959
2022
Q4 		– Sell
-18,177
Closed -$188K – 1172
2022
Q3 		$188K Sell
18,177
-74,900
-80% -$849K 0.01% 994
2022
Q2 		$1.07M Buy
+93,077
New +$1.1M 0.04% 415
2022
Q1 		– Sell
-24,724
Closed -$288K – 951
2021
Q4 		$288K Buy
+24,724
New +$303K 0.01% 340

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Graham Capital Management's IRWD Position: Q2 2026 in Review

Graham Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2026, closing a stake of 30,821 shares — an estimated $108K sold.

Graham Capital Management first reported a position in IRWD in Q4 2021 and held it in 9 quarters. The position peaked at $1.07M in Q2 2022. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Graham Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 30,821 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $108K.
  • Graham Capital Management first reported a position in Ironwood Pharmaceuticals in Q4 2021 and held it in 9 quarters.
  • Graham Capital Management's Ironwood Pharmaceuticals position peaked at $1.07M in Q2 2022.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.